Gamal Collier

Experience

• 

  American Family Insurance

  Jan 1997 - Mar 2000

  Claims Analyst

  Adjudicated and analyzed motor vehicle accidentsSettled bodily injury and physical damage claimsAssisted in recruiting new candidates from University campusesConducted diversity seminars and presentations

• 

  Pfizer

  Mar 2000 - Sept 2006

  Professional Healthcare Representative

  Responsible for sales of Lipitor, Caduet and Zmax to Primary Care and Specialty healthcare providers within private/group practice, healthcare clinic, Pharmacy and hospital settings. Have also been responsible for Norvasc, Viagra, Zithromax and Cardura. Successfully launched division for Caduet and Zmax.

• 

  Novartis

  Sept 2006 - Oct 2009

  Senior Sales Consultant

  Responsible for the sales of Tekturna, Exforge, Diovan, and Lotrel to Primary Care and Specialty healthcare providers within private/group practice, healthcare clinic, Pharmacy, and community/teaching hospital settings. Successfully launched Tekturna and Exforge.

• 

  Applied Medical

  Nov 2009 - Dec 2010

  Territory Manager

  Responsible for the sales of Laparoscopic surgical devices and instruments for abdominal, gynecological, urological and general surgery procedures primarily within hospital and surgical center settings. My responsibilities include surgeon training and instruction in the use of our surgical devices and instruments, attending surgeon training courses, and product evaluations, as well as discussing contracts and pricing within hospital and surgery center management.

• 

  Gbonda Collier Investments (GCI)

  Nov 2010 - now

  CEO/Managing Director

  Gbonda Collier Investments (GCI) is an international consultancy firm that specializes in Project Financing and Management, Trade Finance, Procurements and Investments. -Project Management and Consulting -Government Contracting & Logistics-Procurements -Real Estate -General Construction (Roads, Buildings, Wells, Community Projects, etc.)-General Supplies

• 

  Lion Mountain Investments

  Jan 2011 - now

  CEO/Managing Director

  General Investments and Holding Company: -Real Estate -Investments

• 

  Forest Laboratories

  Sept 2012 - Oct 2014

  Senior Sales Representative

  Responsible for sales of Linzess, Fetzima, Viibryd, Bystolic, and Savella to Primary Care and Specialty healthcare providers within private/group practice, healthcare clinic, Pharmacy, and community/teaching hospital settings. Successfully launched Linzess and Fetzima

• 

  Daiichi Sankyo, Inc.

  Sept 2014 - Apr 2015

  Senior Cardiovascular Specialist

  Responsible for the sales and promotion of Savaysa and Effient to Specialty healthcare providers within private/group practice, healthcare clinic, Pharmacy, and community/teaching hospital settings. Successfully launched Savaysa, a Factor Xa inhibitor which is a new Novel Anticoagulant (NOAC).

• 

  Amgen

  May 2015 - May 2019

  Senior Biopharmaceutical Cardiovascular Specialist

  Responsible for the launch, sales, and promotion of CORLANOR (a first-in-class, HCN channel blocker that lowers heart rate), REPATHA (a new PCSK9 Inhibitor injectable for LDL-C reduction) and AIMOVIG (a new CGRP inhibitor for the preventative treatment of migraine) to Specialty healthcare providers within private/group practice, healthcare clinic, Pharmacy, and community/teaching hospital settings.

• 

  EFC Partners

  Jan 2021 - now

  Managing Director

  EFC Partners is an Economic Finance Company based out of Turkey but with a focus on operations and investments in Africa as well as internationally.